289 related articles for article (PubMed ID: 19482851)
1. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
2. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
Zhang R; Huang Y; Zhang M; Bai J; Liu J
Clin Appl Thromb Hemost; 2012 Sep; 18(5):448-52. PubMed ID: 22679243
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
8. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
[TBL] [Abstract][Full Text] [Related]
10. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis.
Avidan MS; Smith JR; Skrupky LP; Hill L; Jacobsohn E; Burnside B; Tymkew H; Eby C; Damiano R; Despotis GJ
Thromb Res; 2011 Dec; 128(6):524-9. PubMed ID: 21794899
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
13. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Williams RT; Damaraju LV; Mascelli MA; Barnathan ES; Califf RM; Simoons ML; Deliargyris EN; Sane DC
Circulation; 2003 May; 107(18):2307-12. PubMed ID: 12707235
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes.
Mascelli MA; Deliargyris EN; Damaraju LV; Barnathan ES; Sane DC
Semin Thromb Hemost; 2004 Jun; 30(3):347-50. PubMed ID: 15282657
[TBL] [Abstract][Full Text] [Related]
15. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
Look KA; Sahud M; Flaherty S; Zehnder JL
Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
[TBL] [Abstract][Full Text] [Related]
17. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
[TBL] [Abstract][Full Text] [Related]
18. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
19. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
[TBL] [Abstract][Full Text] [Related]
20. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
